HEALTHTRONICS LITHOTRON LIHTOTRIPSY SYSTEM

FDA Premarket Approval P970019 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for modifications to the lithotron(tm) lithotripsy system's labeling to reflect the results of this final report. Based upon the information submitted, fda believes that the postapproval report demonstrates that hypertension is not a long-term risk of extracorporeal shock wave lithotripsy, and that this postapproval requirement is now considered complete.

DeviceHEALTHTRONICS LITHOTRON LIHTOTRIPSY SYSTEM
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantHEALTH TRONICS SURGICAL SERVICES, INC.
Date Received1998-07-23
Decision Date1998-11-18
PMAP970019
SupplementS003
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address HEALTH TRONICS SURGICAL SERVICES, INC. 425 Franklin Rd., Suite 545 marietta, GA 30067

Supplemental Filings

Supplement NumberDateSupplement Type
P970019Original Filing
S006 1999-07-06 Normal 180 Day Track
S005 1998-11-12 Real-time Process
S004 1998-08-27 Real-time Process
S003 1998-07-23 Normal 180 Day Track
S002 1998-05-18 Normal 180 Day Track
S001 1997-11-05 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.